Patents Assigned to ANTECIP BOIVENTURES II LLC
  • Osteoclast inhibitors for knee conditions
    Patent number: 9861648
    Abstract: Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as knee pain.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: January 9, 2018
    Assignee: ANTECIP BOIVENTURES II LLC
    Inventor: Herriot Tabuteau